2018-2023 China Capecitabine Market Report (Status and Outlook)

Publisher Name :
Date: 07-Jun-2018
No. of pages: 87

In 2017, the Capecitabine market size was xx million USD in China, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.

In China market, the top players include

- Roche

- Teva

- Mylan

- Hikma

- Hengrui Medicine

- Cipla

- Reliance Group

- Hetero

Split by product types/category, covering

- 500 mg

- 150 mg

Split by applications/end use industries, covers

- Breast Cancer

- Colorectal cancer

- Stomach Cancer

2018-2023 China Capecitabine Market Report (Status and Outlook)

Table of Contents

2018-2023 China Capecitabine Market Report (Status and Outlook)
1 Capecitabine Market Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Capecitabine Market Segment by Types
1.2.1 China Capecitabine Sales Present Situation and Outlook by Types (2013-2023)
1.2.2 China Capecitabine Sales Market Share by Types in 2017
1.2.3 500 mg
1.2.3.1 Major Players of 500 mg
1.2.4 150 mg
1.2.4.1 Major Players of 150 mg
1.3 China Capecitabine Market Segment by Applications/End Use Industries
1.3.1 China Capecitabine Sales Present Situation and Outlook by Applications/End Industrials (2013-2023)
1.3.2 China Capecitabine Sales Market Share by Applications in 2017
1.3.2 Breast Cancer
1.3.3 Colorectal cancer
1.3.4 Stomach Cancer
1.4 China Capecitabine Overview and Market Size (Value) (2013-2023)
1.4.1 China Market Capecitabine Overview
1.4.2 China Capecitabine Market Size (Value and Volume) Status and Forecast (2013-2023)
2 China Capecitabine Sales, Revenue (Value) and Market Share by Players
2.1 China Capecitabine Sales and Market Share by Players (2013-2018)
2.2 China Capecitabine Revenue and Market Share by Players (2013-2018)
2.3 China Capecitabine Average Price by Players in 2017
2.4 China Capecitabine Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Capecitabine Market Competitive Situation and Trends
2.5.1 Capecitabine Market Concentration Rate
2.5.2 Capecitabine Market Share of Top 3 and Top 5 Players in 2017
2.5.3 Mergers & Acquisitions, Expansion
3 China Capecitabine Sales, Revenue (Value) by Type and Application (2013-2018)
3.1 China Capecitabine Sales, Revenue, Market Share and Price by Type (2013-2018)
3.1.1 China Capecitabine Sales and Market Share by Type (2013-2018)
3.1.2 China Capecitabine Revenue and Market Share by Type (2013-2018)
3.1.3 China Capecitabine Price by Type (2013-2018)
3.2 China Capecitabine Sales and Market Share by Application (2013-2018)
3.3 China Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
4 China Capecitabine Players Profiles and Sales Data
4.1 Roche
4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.1.2 Capecitabine Product Types, Application and Specification
4.1.2.1 Type 1
4.1.2.2 Type 2
4.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.1.4 Main Business/Business Overview
4.1.5 Roche News
4.2 Teva
4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.2.2 Capecitabine Product Types, Application and Specification
4.2.2.1 Type 1
4.2.2.2 Type 2
4.2.3 Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.2.4 Main Business/Business Overview
4.2.5 Teva News
4.3 Mylan
4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.3.2 Capecitabine Product Types, Application and Specification
4.3.2.1 Type 1
4.3.2.2 Type 2
4.3.3 Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.3.4 Main Business/Business Overview
4.3.5 Mylan News
4.4 Hikma
4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.4.2 Capecitabine Product Types, Application and Specification
4.4.2.1 Type 1
4.4.2.2 Type 2
4.4.3 Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.4.4 Main Business/Business Overview
4.4.5 Hikma News
4.5 Hengrui Medicine
4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.5.2 Capecitabine Product Types, Application and Specification
4.5.2.1 Type 1
4.5.2.2 Type 2
4.5.3 Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.5.4 Main Business/Business Overview
4.5.5 Hengrui Medicine News
4.6 Cipla
4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.6.2 Capecitabine Product Types, Application and Specification
4.6.2.1 Type 1
4.6.2.2 Type 2
4.6.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.6.4 Main Business/Business Overview
4.6.5 Cipla News
4.7 Reliance Group
4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.7.2 Capecitabine Product Types, Application and Specification
4.7.2.1 Type 1
4.7.2.2 Type 2
4.7.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.7.4 Main Business/Business Overview
4.7.5 Reliance Group News
4.8 Hetero
4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
4.8.2 Capecitabine Product Types, Application and Specification
4.8.2.1 Type 1
4.8.2.2 Type 2
4.8.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
4.8.4 Main Business/Business Overview
4.8.5 Hetero News
5 China Capecitabine Market Forecast (2018-2023)
5.1 China Capecitabine Sales, Revenue and Price Forecast (2018-2023)
5.1.1 China Capecitabine Sales and Growth Rate Forecast (2018-2023)
5.1.2 China Capecitabine Revenue and Growth Rate Forecast (2018-2023)
5.1.3 China Capecitabine Price Trend Forecast (2018-2023)
5.2 China Capecitabine Sales Forecast by Type (2018-2023)
5.3 China Capecitabine Sales Forecast by Application (2018-2023)
6 Production Cost Analysis of Capecitabine
6.1 Main Raw Materials of Capecitabine
6.1.1 List of Capecitabine Main Raw Materials
6.1.2 Capecitabine Main Raw Materials Price Analysis
6.1.3 Capecitabine Raw Materials Major Suppliers
6.1.4 Capecitabine Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Capecitabine
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Production Expenses
6.3 Capecitabine Manufacturing Process/Method
7 Value Chain, Purchasing Strategy and Downstream Buyers
7.1 Capecitabine Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Capecitabine Major Players in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Sales Channel
8.1.1 Direct Sales
8.1.2 Indirect Sales
8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Capecitabine Distributors/Traders List in China
9 Market Influences Factors Analysis
9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Data Source

List of Tables and Figures

Figure Picture of Capecitabine
Table Product Specifications of Capecitabine
Figure China Capecitabine Sales (volume) for Each Type (2013-2023)
Figure China Capecitabine Sales Market Share by Types in 2017
Table Types of Capecitabine
Figure Product Picture of 500 mg
Table Major Players of 500 mg
Figure Product Picture of 150 mg
Table Major Players of 150 mg
Figure China Capecitabine Sales Present Situation and Outlook by Applications (2013-2023)
Figure China Capecitabine Sales Market Share by Applications in 2017
Table Applications of Capecitabine
Figure Breast Cancer Examples
Figure Colorectal cancer Examples
Figure Stomach Cancer Examples
Figure China Capecitabine Revenue (Million USD) Status and Forecast (2013-2023)
Figure China Capecitabine Sales (Volume) Status and Forecast (2013-2023)
Table China Capecitabine Sales by Players (2013-2018)
Table China Capecitabine Sales Market Share (%) by Players (2013-2018)
Figure China Capecitabine Sales Market Share by Players in 2016
Figure China Capecitabine Sales Market Share by Players in 2017
Table China Capecitabine Revenue (Million USD) by Players (2013-2018)
Table China Capecitabine Revenue Market Share (%) by Players (2013-2018)
Figure China Capecitabine Revenue Market Share by Players in 2016
Figure China Capecitabine Revenue Market Share by Players in 2017
Figure China Capecitabine Average Price by Players in 2017
Table China Capecitabine Manufacturing Base Distribution and Sales Area by Players
Table Players Capecitabine Product Types
Figure Capecitabine Market Share of Top 3 Players in 2017
Figure Capecitabine Market Share of Top 5 Players in 2017
Table China Capecitabine Sales by Type (2013-2018)
Table China Capecitabine Sales Market Share by Type (2013-2018)
Figure China Capecitabine Sales Market Share by Type in 2013
Figure China Capecitabine Sales Market Share by Type in 2017
Table China Capecitabine Revenue (Million USD) by Type (2013-2018)
Table China Capecitabine Revenue Market Share by Type (2013-2018)
Figure China Capecitabine Revenue Market Share by Type in 2013
Figure China Capecitabine Revenue Market Share by Type in 2017
Table China Capecitabine Price by Type (2013-2018)
Table China Capecitabine Sales by Application (2013-2018)
Table China Capecitabine Sales Market Share by Application (2013-2018)
Figure China Capecitabine Sales Market Share by Application (2013-2018)
Figure China Capecitabine Sales Market Share by Application in 2017
Table China Market Capecitabine Sales, Revenue (Million USD), Price and Gross Margin (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Capecitabine Market Share (2012-2017)
Table Teva Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Teva Capecitabine Market Share (2012-2017)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Mylan Capecitabine Market Share (2012-2017)
Table Hikma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hikma Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hikma Capecitabine Market Share (2012-2017)
Table Hengrui Medicine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hengrui Medicine Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hengrui Medicine Capecitabine Market Share (2012-2017)
Table Cipla Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Capecitabine Market Share (2012-2017)
Table Reliance Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Market Share (2012-2017)
Table Hetero Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Hetero Capecitabine Market Share (2012-2017)
Figure China Capecitabine Sales and Growth Rate Forecast (2018-2023)
Figure China Capecitabine Revenue and Growth Rate Forecast (2018-2023)
Figure China Capecitabine Price Trend Forecast (2018-2023)
Table China Capecitabine Sales Forecast by Type (2018-2023)
Figure China Capecitabine Sales Market Share Forecast by Type (2018-2023)
Figure China Capecitabine Sales Market Share Forecast by Type in 2023
Table China Capecitabine Sales Forecast by Application (2018-2023)
Figure China Capecitabine Sales Market Share Forecast by Application (2018-2023)
Figure China Capecitabine Sales Market Share Forecast by Application in 2023
Table Production Base and Market Concentration Rate of Raw Material
Figure Capecitabine Main Raw Materials Price Trend
Table Capecitabine Raw Materials Major Suppliers List
Figure Production Cost Structure of Capecitabine
Figure Capecitabine Manufacturing Process/Method
Figure Capecitabine Value Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players in 2017
Table Major Buyers of Capecitabine
Table Capecitabine Distributors/Traders List in China
  • Global Topotecan Hydrochloride Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 131
    Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted fr......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Topotecan Hydrochloride Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 131
    Topotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase I-DNA covalent complexes, inhibiting religation of topoisomerase I-mediated single-strand DNA breaks and producing potentially lethal double-strand DNA breaks when complexes are encountered by the DNA replication machinery. Camptothecin is a cytotoxic quinoline-based alkaloid extracted fr......
  • Global Paclitaxel Injection Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 13-Jun-2018        Price: US 3480 Onwards        Pages: 130
    Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers. Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks. ......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Paclitaxel Injection Market 2018, Forecast to 2023
    Published: 13-Jun-2018        Price: US 4880 Onwards        Pages: 133
    Paclitaxel Injection is a kind of anti-cancer injection taking paclitaxel API as raw material. It is mainly used in breast cancer, ovarian cancer and other cancers. Paclitaxel injection comes as a liquid to be given intravenously (into a vein) by a doctor or nurse in a hospital or clinic. It is usually given once every 3 weeks. When paclitaxel injection manufactured with polyoxyethylated castor oil is used to treat Kaposi's sarcoma, it may be given once every 2 or 3 weeks. ......
  • 2018-2023 Global Top Countries Capecitabine Market Report
    Published: 07-Jun-2018        Price: US 4960 Onwards        Pages: 126
    In 2017, the global Capecitabine market size was xx million USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Capecitabine in Global market, especially in United States, Canada, Mexico, Germany, France, UK, Italy, Russia, China, Japan, India, Korea, Southeast Asia, Australia, Brazil, Middle East and Africa, focuses on the top Players in each country, covering - Roche - Teva - Mylan - Hikma -......
  • 2018-2023 India Capecitabine Market Report (Status and Outlook)
    Published: 07-Jun-2018        Price: US 3360 Onwards        Pages: 87
    In 2017, the Capecitabine market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In India market, the top players include - Roche - Teva - Mylan - Hikma - Hengrui Medicine - Cipla - Reliance Group - Hetero Split by product types/category, covering - 500 mg - 150 mg Split by applications/end use industries, covers......
  • 2018-2023 Malaysia Capecitabine Market Report (Status and Outlook)
    Published: 07-Jun-2018        Price: US 3360 Onwards        Pages: 87
    In 2017, the Capecitabine market size was xx million USD in Malaysia, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Malaysia market, the top players include - Roche - Teva - Mylan - Hikma - Hengrui Medicine - Cipla - Reliance Group - Hetero Split by product types/category, covering - 500 mg - 150 mg Split by applications/end use industries, cove......
  • 2018-2023 Philippines Capecitabine Market Report (Status and Outlook)
    Published: 07-Jun-2018        Price: US 3360 Onwards        Pages: 87
    In 2017, the Capecitabine market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. In Philippines market, the top players include - Roche - Teva - Mylan - Hikma - Hengrui Medicine - Cipla - Reliance Group - Hetero Split by product types/category, covering - 500 mg - 150 mg Split by applications/end use industries......
  • 2018 Top 5 Capecitabine Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa
    Published: 07-Jun-2018        Price: US 4960 Onwards        Pages: 126
    The Global Capecitabine market size will be XX million (USD) in 2023, from the XX million (USD) in 2017, with a CAGR (Compound Annual Growth Rate) of XX% from between 2017 and 2023. This report studies the global Capecitabine market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 Capecitabine players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players including - Roche......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs